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Abstract
Earlier we reported that atherosclerotic plaques contain cells which were specifically and very intensively stained with anti-
GM3 antibodies although no GM3 positive cells were detected in the normal non-diseased arterial intima. Because of their
lipid inclusions, GM3 positive cells in atherosclerotic lesions seemed to be foam cells but their origin needed clarification.
Using an immunohistochemical technique in the present work, we showed that some of these foam cells contained CD68
antigen. However, the most intense accumulation of GM3 occurred in the areas composed of foam cells which did not stain
with any cell type-specific antibodies, including antibodies to macrophages (anti-CD68) and smooth muscle cells (anti-
smooth muscle K-actin), perhaps, because the cell type-specific antigens were lost during the transformation of intimal cells
into foam cells. Ultrastructural analysis of the areas where foam cells overexpressed GM3 demonstrated that some foam cells
lacked both a basal membrane and myofilaments but contained a large number of secondary lysosomes and phagolysosomes,
morphological features which might indicate their macrophage origin. Other foam cells contained a few myofilaments and
fragments of basal membrane around their plasmalemmal membrane, suggesting a smooth muscle cell origin. These
observations indicate that accumulation of excessive amounts of GM3 occurs in different cell types transforming into foam
cells. We suggest that up-regulation of GM3 synthesis in intimal cells might be an essential event in foam cell formation.
Shedding of a large number of membrane-bound microvesicles from the cell surface of foam cells was observed in areas of
atherosclerotic lesions corresponding to extracellular GM3 accumulation. We speculate that extracellularly localised GM3
might affect the differentiation and modification of intimal cells in atherosclerotic lesions. ß 2001 Elsevier Science B.V. All
rights reserved.
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1. Introduction
Foam cells in atherosclerotic lesions are derived
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from vascular smooth muscle cells (VSMC) and from
macrophages that originate from circulating
monocytes [1^3]. Monocytes/macrophages which in-
¢ltrate the arterial intima synthesise and release a
great number of biologically potent substances, in-
cluding growth factors, interleukins, enzymes, and
adhesive glycoproteins [1]. These factors lead
VSMC to migrate from the media into the intima
and to undergo structural and functional changes
from contractile to synthetic phenotype [1]. Since
the in¢ltration of monocytes into the arterial intima
seems to precede the VSMC phenotypic modulation,
factors released by monocytes/macrophages are
thought to be responsible for the VSMC modi-
¢cation from the very early stages of atherogenesis
[1^3]. By actively taking up the lipoprotein cho-
lesterol through receptor-mediated endocytosis,
both macrophages and modulated VSMC transform
into foam cells [1,4]. The signals controlling the cell
phenotypic modi¢cation and foam cell formation
have been intensely studied [1], but the precise mech-
anisms responsible for these processes are still un-
known.
Glycosphingolipids (GSL) are implicated in cell
modi¢cation as a modulator of signal transduction,
particularly through their e¡ects on growth factor
receptors and protein kinase activity [5]. GSL con-
taining neuraminic acids and gangliosides are local-
ised at the cell surface and are involved in cell adhe-
sion, cell to cell interaction and cell di¡erentiation
[6^8]. Ganglioside GM3 is excessively incorporated
in VSMC in atherosclerotic intima but not in cells
in normal areas of human arteries [9,10]. Recently we
demonstrated that atherosclerotic plaques contain
cells speci¢cally and very intensively stained with
anti-GM3 antibodies while GM3 positive cells were
absent from normal, non-diseased intima [11]. In the
present study, we have measured the GM3 content in
aortic atherosclerotic plaques and the intima taken
from non-diseased areas and examined the nature of
cells expressing GM3 in plaques.
2. Materials and methods
The present investigation conformed with the
principles outlined in the Declaration of Helsinki
[12].
2.1. Tissue preparation for biochemical analysis of
GM3 content
Twelve aortic samples were obtained 1.5^3 h post-
mortem from male subjects between 40 and 60 years
of age who had died suddenly from myocardial in-
farction. The types of atherosclerotic lesions were
assessed according to the classi¢cation suggested by
Smith [13]. Regions of uninvolved aortic tissue and
areas a¡ected by atherosclerotic plaques were excised
from each aortic sample and the intima was sepa-
rated from the media.
2.2. Isolation and quanti¢cation of GM3
Intimal samples were extracted using a chloro-
form^methanol mixture, lipids were treated with
0.2 N NaOH, neutralised, desalted on a C18-Sep-
Pak cartridge (Millipore Corp., USA), and ganglio-
sides were obtained by ion-exchange chromatogra-
phy on a DEAE-Sephadex column as described pre-
viously [14]. Gangliosides were fractionated on
HPTLC plates (Merck, Germany) and GM3 quanti-
tative analysis on chromatograms was performed by
densitometry [14]. The GM3 contents of intimal pla-
ques and uninvolved intima from the same aorta
were compared in every case. Statistical analysis
was performed using Graphpad Instar software.
2.3. Tissue specimens used for immunohistochemical
study
Aortic specimens were collected during aortic re-
constructions at St. Vincent’s Hospital, Sydney, Aus-
tralia. For immunohistochemistry, un¢xed samples
were immediately embedded in OCT compound, rap-
idly frozen in liquid nitrogen and stored at 370‡C
until cryostat sectioning. For electron microscopic
examination, small tissue pieces were cut from each
specimen and ¢xed in 2.5% glutaraldehyde in phos-
phate-bu¡ered saline (PBS), pH 7.2.
Some characteristics of this material have previ-
ously been reported [15]. For the present work, arte-
rial wall segments of 11 aortas from patients whose
ages ranged from 56 to 71 years were used. The
arterial specimens selected for immunohistochemical
examination included atherosclerotic lesions and
areas of the adjacent normal appearing arterial wall.
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2.4. Antibodies against ganglioside GM3 and oxidised
LDL (ox-LDL)
Antibodies against the human ganglioside GM3
were obtained as previously reported [11]. In the
present immunohistochemical study the antibody
was used in two working concentrations, namely,
130 Wg/ml and 283 Wg/ml. Ox-LDL were identi¢ed
with anti-ox-LDL antibodies (Biomedica, a kind
gift of Dr F. Tatzberg) in 1:10 dilution as previously
used [16].
2.5. Immunohistochemical identi¢cation of cell types
Macrophages were identi¢ed with anti-CD68
(Dako; EBM11; diluted 1:50). VSMC were identi-
¢ed with anti-smooth muscle K-actin (Dako; 1A4;
diluted 1:50). T cells were identi¢ed with anti-CD3
(Dako; MO835; diluted 1:20). Dendritic cells were
identi¢ed with anti-CD83 (PharMingen; HB15e; di-
luted 1:25). Endothelial cells were identi¢ed using
anti-von Willebrand factor antibody (Dako; F8/86;
diluted 1:50).
2.6. Single immunostaining procedure
After eliminating endogenous peroxidase activity
by 0.3% H2O2 for 5 min, the consecutive sections
were preincubated with normal goat serum, then in-
cubated for 30 min with antibodies to GM3, ox-
LDL, smooth muscle K-actin, CD68, CD83, CD3
and von Willebrand factor and were tested by
Fig. 1. Immunostaining of the non-diseased intima (A) and atherosclerotic intima (C) with antibody to GM3 in 283 Wg/ml concentra-
tion. In (A, C), note the pale immunostaining of smooth muscle cells. In (C), foam cells overexpressing GM3 are shown by arrows.
Human aorta. ABC immunoperoxidase technique. (B) Negative control. Counterstaining with Mayer’s haematoxylin. Original magni¢-
cation: U400, U400, U400.
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avidin^biotin complex using the ABC immunoperox-
idase method [17]. After washing in Tris^PBS
(TPBS), pH 7.6, for 10 min, the sections were incu-
bated for 20 min with an appropriate secondary anti-
body (Dako). The sections were then washed in
TPBS for 5 min and treated with avidin^biotin com-
plex (ELITE-ABC, VECTOR PK6100) for 30 min.
After washing for 10 min in TPBS, a brown staining
was produced by treating the sections with 3,3P-di-
aminobenzidine (DAB). All incubations were per-
formed at room temperature. For negative controls,
the primary antibody was omitted or the sections
were treated with an immunoglobulin fraction of
non-immune goat serum (VECTOR S-1000) as a
substitute for the primary antibody. None of the
negative control sections showed positive immune
staining. Counterstaining was performed with May-
er’s haematoxylin. Sections were examined in an
Olympus microscope at 10U10 and 10U40 magni¢-
cations.
2.7. Double immunostaining procedures used for
identifying co-localisation of ganglioside GM3
with ox-LDL
For double immunostaining, staining with anti-
GM3 antibody in a 130 Wg/ml concentration was
performed using the same protocol as for the single
immunostaining procedure. After visualisation of the
GM3 localisation with anti-GM3 antibody, the tissue
sections were washed several times during 120 min
with 0.1 M glycine^hydrochloric bu¡er (pH 2.2) at
4‡C. After incubation with normal goat serum, the
sections were further incubated at 4‡C overnight with
the antibody against ox-LDL. The sections were then
washed in TPBS and incubated with biotin-labelled
secondary antibody for 20 min (LSAB kit, Dako).
The peroxidase reaction was developed with 3-ami-
no-9-ethylcarbazole substrate-chromogen system
(AEC substrate kit, Dako). For negative controls,
the primary antibodies were omitted or the sections
were treated with an immunoglobulin fraction of
non-immune goat serum (VECTOR S-100) as substi-
tute for the primary antibodies. None of the negative
control sections showed positive immune staining.
Counterstaining was performed with Mayer’s haema-
toxylin.
2.8. Preparation of specimens for electron microscopic
analysis
After ¢xation of aortic samples in 2.5% glutaral-
dehyde in PBS (pH 7.2), specimens were post¢xed in
1% osmium tetroxide, dehydrated in graded ethanol
and propylene oxide, and then embedded in Araldite
resin. Semithin and ultrathin sections were cut on a
LKB-III ultratome. Ultrathin sections were stained
with uranyl acetate and lead citrate and examined
with aid of a Hitachi H7000 electron microscope at
an accelerating voltage of 75 kV.
3. Results
3.1. GM3 content in atherosclerotic plaques and
una¡ected regions of the human aortic intima
Atherosclerotic plaques and una¡ected regions of
the same aortas were found to contain 149+77 and
33+13 Wg of GM3 per g wet tissue, respectively. All
12 aortic samples showed a 3^8-fold higher content
of GM3 in plaques than in una¡ected regions. To
compare the value of a variable in two groups (pla-
ques and una¡ected regions), a paired non-paramet-
ric test was used. The two-tailed P value was 0.0005.
3.2. Immunohistochemical analysis of GM3
distribution using di¡erent dilutions of antibodies
to GM3
We previously reported that anti-GM3 antibody
used in a 130 Wg/ml concentration did not stain cells
6
Fig. 2. Co-localisation of ganglioside GM3 (A) with ox-LDL (B) identi¢ed in consecutive sections (A, B) and by double immunostain-
ing (C, D) in atherosclerotic lesions. In (A, B), cells containing both GM3 (A) and ox-LDL (B) are shown by arrows. (A, B) ABC
immunoperoxidase technique; counterstaining with Mayer’s haematoxylin. (C, D) Double immunostaining resulting in brown staining
of GM3 positive material (immunoperoxidase technique utilising DAB) and red staining of ox-LDL (immunoperoxidase technique uti-
lising the AEC substrate kit). Counterstaining with Mayer’s haematoxylin. Original magni¢cation: U400, U400, U400, U400.
BBADIS 61990 19-1-01 Cyaan Magenta Geel Zwart
Y.V. Bobryshev et al. / Biochimica et Biophysica Acta 1535 (2001) 87^99 91
BBADIS 61990 19-1-01 Cyaan Magenta Geel Zwart
Y.V. Bobryshev et al. / Biochimica et Biophysica Acta 1535 (2001) 87^9992
in non-atherosclerotic areas of human arterial wall
[11]. We suggested that this was because the content
of GM3 in cells of una¡ected areas of human intima
was low [11]. To investigate GM3 localisation in cells
in non-diseased intima, in the present work we have
stained sections of non-atherosclerotic aortic wall
with anti-GM3 antibodies in a higher concentration
than previously [11]. Staining of the normal, non-
diseased intima with antibody to GM3 in a 283
Wg/ml concentration demonstrated a low but speci¢c
expression of GM3 by VSMC in the aortic wall
(Fig. 1A) while no positive immunostaining was ob-
served in control sections (Fig. 1B). Immunostaining
of sections of atherosclerotic plaques with anti-GM3
antibody in a 283 Wg/ml concentration showed in-
tense staining of foam cells (Fig. 1C); other intimal
cells which did not show signs of transformation into
foam cells were characterised by a low intensity of
positive immunostaining (Fig. 1C).
Staining of sections of both normal and athero-
sclerotic intima with anti-GM3 antibody in a
130 Wg/ml concentration showed patterns of GM3
distribution similar to those described by us earlier
[11], namely, no positive immunostaining was de-
tected in the normal arterial wall while in athero-
sclerotic lesions GM3 positive immunostaining was
consistently observed in all 11 specimens studied.
This immunopositive staining was restricted to
foam cells, suggesting that the GM3 overexpression
is associated with intracellular lipid accumulation
(Fig. 2A), and to the areas containing destroyed
foam cells. As the aim of the present work was to
investigate the nature of cells overexpressing GM3 in
atherosclerotic lesions, in further immunostaining,
the antibody to GM3 was used in a 130 Wg/ml con-
centration only.
3.3. Immunohistochemical analysis of co-localisation
of GM3 with ox-LDL in atherosclerotic lesions
Comparison of parallel consecutive sections
stained with the antibody to GM3 and the antibody
to ox-LDL demonstrated that the patterns of their
distribution were often congruent (Fig. 2A,B). Dou-
ble immunostaining con¢rmed frequent co-localisa-
tion of GM3 with ox-LDL within foam cells and in
areas of destruction of foam cells (Fig. 2C,D). Anal-
ysis of consecutive sections stained with antibody to
GM3 and ox-LDL as well as with cell type-speci¢c
antibodies including antibodies to CD68, CD83,
CD3, smooth muscle K-actin and von-Willebrand
factor, showed that patterns of distribution of both
GM3 and ox-LDL most often corresponded to the
areas containing CD68 positive foam cells (Fig. 3A^
D) while their co-localisation with smooth muscle
K-actin and CD3 was not observed.
3.4. Ultrastructural analysis of atherosclerotic areas
corresponding to sites where foam cells
overexpressed GM3 and where massive
accumulation of extracellular GM3 occurred
By electron microscopy we analysed atheroscler-
otic areas which corresponded to the sites where
the intra- and extracellular accumulations of GM3
and modi¢ed LDL were most frequently seen at
the immunochemical examination. These areas in-
cluded sites containing large numbers of foam cells.
From the ultrastructural appearance of some foam
cells it was possible to determine their origin. Many
foam cells contained a large number of lipid vacu-
oles, lysosomes, and phagolysosomes of di¡erent
sizes but did not have the basal membrane around
Fig. 3. Accumulation and co-localisation of GM3 (A, B) with ox-LDL (C) and CD68 (D) in an atherosclerotic lesion. (B) is a detail
of (A). (B, C, D) are parallel consecutive sections. (A^D) ABC immunoperoxidase technique. Counterstaining with Mayer’s haematox-
ylin. Original magni¢cations: U100, U400, U400, U400.
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Fig. 4. Foam cells of macrophage origin and their destruction in human atherosclerotic plaques. (A) Foam cell containing a large
number of phagolysosomes but lacking myo¢laments and basal lamina which suggests its macrophage origin. (B) Detail of peripheral
cytoplasm surrounded by intact plasmalemma. (C) Detail of peripheral cytoplasm showing complete destruction of its plasmalemma
(arrows). (D) Complete destruction of a foam cell resulting in the formation of multiple microvesicles (arrows). In (A^D), L^lipid
droplet. In (A, B), F^phagolysosome; V^vacuole. Original magni¢cations: U10 000, U30 000, U30 000, U30 000.
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Fig. 5. Foam cells of smooth muscle cell origin. Accumulation of lipids (A), fragmentation of cytoplasm (solid arrows) (B), shedding
of microvesicles from the plasmalemmal surface into the extracellular space (solid arrows) (C), and intracellular accumulation of multi-
ple vesicles (solid arrows) (D) in degenerating smooth muscle cells in human atherosclerotic plaques. L^Lipid droplet. In (A, D), note
that all cells contain varying numbers of myo¢laments (open arrows) as well as remnants of the basal lamina. Original magni¢cations:
U10 000, U20 000, U30 000, U20 000.
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their plasmalemma and no myo¢laments in their cy-
toplasm were seen (Fig. 4A,B). This allowed them to
be identi¢ed as foam cells of macrophage origin (Fig.
4A,B). Destruction of the plasmalemma in some of
these foam cells resulted in the release of lipid drop-
lets into the extracellular space (Fig. 4C). Some foam
cells showed complete destruction with their cyto-
plasm shattered into a large number of microvesicles
of di¡ering sizes (Fig. 4D). Other foam cells con-
tained some myo¢laments and fragments of the basal
membrane around their plasmalemmal membrane,
suggesting a smooth muscle cell origin (Fig. 5A,D).
Apart from the accumulation of lipids, the fragmen-
tation of the cytoplasm and the shedding of micro-
vesicles from the plasmalemmal surface into the
extracellular space were commonly seen in foam cells
of VSMC origin (Fig. 5B,C). Intracellular accumula-
tion of multiple vesicles in the cytoplasm of degener-
ating foam cells of VSMC origin was also usual (Fig.
5D). As a result of cell death, multiple microvesicles
of di¡ering size accumulated in the extracellular
space (Fig. 6A^E). In these areas, extracellularly lo-
cated microvesicles were intermingled with lipids and
collagen ¢bres (Fig. 6B^E). The formation of choles-
terol clefts among the extracellularly located micro-
vesicles and lipid droplets was also observed (Fig.
6D).
4. Discussion
Normal animal and human tissues are character-
ised by a consistent composition and content of gan-
gliosides [6]. Changes in the composition and/or
content of tissue gangliosides are related to di¡eren-
tiation, transformation or proliferation and occur
during embryogenesis, tumourogenesis and other
various physiological and pathophysiological pro-
cesses [7,8].
While investigating gangliosides in normal and
atherosclerotic human aorta, we found that the gan-
glioside content in VSMC from atherosclerotic inti-
ma was about 2.5 times higher than that in cells from
una¡ected intima [9]. In the present study, a 5-fold
increase in GM3, a major intimal ganglioside [13],
was demonstrated in atherosclerotic plaques in con-
trast to non-diseased intimal areas of the same aorta.
This agrees with immunohistochemical observations
that atherosclerotic plaques contain cells that specif-
ically and very intensely react with the anti-GM3
antibody. In non-atherosclerotic areas, VSMC did
not react with anti-GM3 antibody in a 130 Wg/ml
concentration but showed a low but speci¢c expres-
sion of GM3 when anti-GM3 antibody was used at a
higher concentration of 283 Wg/ml. These ¢ndings
indicate that intense expression of GM3 by foam
cells identi¢ed at a 130 Wg/ml concentration of the
antibody represents overexpression of GM3 in cells
accumulating excessive lipids in their cytoplasm.
The initiating event of atherosclerotic plaque for-
mation is LDL in£ux into the arterial wall followed
by oxidation of LDL [1,18]. Accumulation of oxi-
dised forms of LDL is a characteristic feature of
atherosclerotic lesions [1,18^20]. Double immuno-
staining with anti-GM3 and anti-ox-LDL antibodies
showed that both GM3 and ox-LDL were co-local-
ised in intimal areas consisting of foam cells. How-
ever, the GM3 accumulation in foam cells cannot be
explained by the uptake of LDL by intimal cells as
we have previously shown that the fatty acid compo-
sition of GM3 in atherosclerotic plaques di¡ers from
that in LDL (the latter being similar to that in the
normal intima) [9^11]. This implies that GM3 in
atherosclerotic intima is synthesised directly in inti-
mal cells and is not delivered into the arterial wall
together with blood LDL [11]. We consider that
GM3 content increases through a mechanism di¡er-
ent from that leading to the accumulation of ox-LDL
C
Fig. 6. Accumulation of multiple microvesicles in the extracellular matrix in human atherosclerotic plaques. (A) Complete destruction
of foam cells of smooth muscle cell origin resulting in the release of microvesicles into the extracellular space. Solid arrows show mi-
crovesicles located in destruction zones of the basal membrane while curved open arrows show microvesicles located at a distance
from the cell. Straight open arrows show intracellularly located remnants of myo¢lamentous material. L^Lipid droplet. (B) Multiple
microvesicles located extracellularly. (C) Lipid droplets (L) located amongst microvesicles in the extracellular space. (D) Remnant of a
foam cell consisting of multiple microvesicles and cholesterol clefts (stars) surrounded by a shell composed of compressed collagen ¢-
bres (arrows). (E) Bundles of collagen ¢bres (arrows) intermingled with extracellularly located microvesicles. Original magni¢cations:
U25 000, U30 000, U30 000, U10 000, U30 000.
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in intimal lesions. Nevertheless, their co-localisation
might be a signi¢cant event in foam cell formation.
Using an immunohistochemical technique, we
have demonstrated that the most intense accumula-
tion of GM3 occurred in the areas where foam cells
did not stain with any cell type-speci¢c antibodies.
This might indicate that the cell type-speci¢c antigens
were lost during transformation of intimal cells into
foam cells. Ultrastructural analysis of intimal areas
consisting of foam cells overexpressing GM3 showed
that this cell population is heterogenous and includes
foam cells of macrophage origin, and foam cells orig-
inating from VSMC, as well as foam cells whose
nature we could not determine. These observations
suggest that the accumulation of an excessive
amount of GM3 occurs in foam cells independently
of their origin. Phenotype modulation precedes foam
cell formation [21,22] and seems to involve changes
in GM3 content. Whether intracellular accumulation
of excessive amounts of GM3 may trigger transfor-
mation of intimal cells into foam cells remains to be
studied.
That VSMC contain GM3 is well established [9].
The suggestion that accumulation of excessive
amounts of GM3 might occur in VSMC transform-
ing into foam cells agrees with previous data ob-
tained by biochemical methods [9,10].
The present study revealed that the up-regulation
of GM3 synthesis occurred in foam cells containing
macrophage CD68 antigen. Di¡erentiation-depen-
dent regulation of the ganglioside level associated
with changes into macrophage-like cell phenotype
has been studied in vitro [23^25] and an elevation
of GM3 content has been detected during the mono-
cyte/macrophage-like di¡erentiation in many human
myelocytic and monocytic leukaemia cell lines (HL-
60, K562, KG-1, ML-1, HO and U937) treated with
12-tetradecanoyl phorbol 13-acetate and related
agents (phorbol esters) [23,26,27]. In contrast, a re-
markable decrease in the content of GM3 and other
GSL occurred during granulocytic di¡erentiation of
HL-60 cells. An increase in the GM3 level in mono-
cyte/macrophage-like cells treated with phorbol es-
ters coincided with a more than 10-fold increase in
the activity of the GM3-synthesising enzyme CMP-
N-acetylneuraminic acid:lactosylceramide sialyltrans-
ferase [27]. The e¡ect of phorbol esters on this en-
zyme is indirect since the enzymatic activity from
crude homogenate of HL-60 cells is not altered by
phorbol esters. The e¡ect of phorbol ester is medi-
ated by the signal transduction pathway from protein
kinase C through mitogen-activated protein kinases
and the activation of c-jun/AP-1 nuclear protein fac-
tors [27]. Di¡erentiation-dependent regulation of the
glycosyl transferase level associated with a strong
enhancement of transcription factors, particularly
AP-1, and with changes in the expression of the cor-
responding GSL on the cell surfaces has been de-
scribed for human embryonal carcinoma cells [5].
Previously we reported that not only cells but also
focal areas of the extracellular matrix in atheroscler-
otic plaques intensively stained with anti-GM3 anti-
body [11]. The present study demonstrates the shed-
ding of microvesicles from the plasmalemmal surface
of foam cells into the extracellular space. Shedding of
multiple microvesicles from the cell surface and the
destruction of intimal cells are the possible explana-
tion for the accumulation of GM3 in the extracellu-
lar areas. As GM3 itself is highly potent in inducing
the monocytic/macrophage-like di¡erentiation [23],
GM3 accumulating in the extracellular matrix might
stimulate di¡erentiation of monocytes newly arrived
from the blood stream.
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